Harvard Bioscience Inc. (HBIO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
14 Jun 2024 |
GREEN JAMES W |
Chief Executive Officer |
13 Jun 2024 |
10,000 |
2.91 |
29,100 |
07 Jun 2024 |
GREEN JAMES W |
Chief Executive Officer |
06 Jun 2024 |
20,000 |
3.07 |
61,400 |
21 Aug 2023 |
GREEN JAMES W |
Chief Executive Officer |
17 Aug 2023 |
25,000 |
4.38 |
109,500 |
16 Mar 2023 |
EDRICK ALAN I |
Director |
15 Mar 2023 |
16,192 |
2.62 |
42,423 |
16 Mar 2023 |
EDRICK ALAN I |
Director |
14 Mar 2023 |
13,808 |
2.67 |
36,867 |
15 Mar 2023 |
GREEN JAMES W |
Chief Executive Officer |
15 Mar 2023 |
20,000 |
2.60 |
52,000 |
15 Mar 2023 |
GREEN JAMES W |
Chief Executive Officer |
14 Mar 2023 |
20,000 |
2.67 |
53,400 |
02 Dec 2022 |
GREEN JAMES W |
Chief Executive Officer |
01 Dec 2022 |
15,000 |
2.61 |
39,150 |
02 Dec 2022 |
GREEN JAMES W |
Chief Executive Officer |
30 Nov 2022 |
15,000 |
2.41 |
36,150 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock